Position dérivée des transactions déclarées les plus récentes. Non ajustée des splits ni des conversions de classes d'actions.
| Émetteur | Actions | Source | Dernière tx | Détail |
|---|---|---|---|---|
| Surrozen, Inc./DE | 5 550 | déclaré | 13 mai 2026 | tx 5+48 216 |
| NGM BIOPHARMACEUTICALS INC | 0 | déclaré | 05 avr. 2024 | tx 43+4 841 300−6 059 025 |
| Date | Type | Émetteur | Quantité | Prix | Signaux |
|---|---|---|---|---|---|
| 13 mai 2026 | GRANT_AWARD | Surrozen, Inc./DE | 5 550 | 0.00 USD | deriv |
| 14 mai 2025 | GRANT_AWARD | Surrozen, Inc./DE | 1 333 | 0.00 USD | deriv |
| 05 juin 2024 | GRANT_AWARD | Surrozen, Inc./DE | 1 333 | 0.00 USD | deriv |
| 05 avr. 2024 | TENDER | NGM BIOPHARMACEUTICALS INC | 23 993 | — | |
| 05 avr. 2024 | TENDER | NGM BIOPHARMACEUTICALS INC | 97 654 | — | |
| 05 avr. 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 87 013 | — | deriv |
| 05 avr. 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 57 833 | — | deriv |
| 05 avr. 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 500 000 | — | deriv |
| 05 avr. 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 200 000 | — | deriv |
| 05 avr. 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 400 000 | — | deriv |
| 05 avr. 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 450 000 | — | deriv |
| 05 avr. 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 500 000 | — | deriv |
| 05 avr. 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 381 600 | — | deriv |
| 05 avr. 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 500 000 | — | deriv |
| 05 avr. 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 95 400 | — | deriv |
| 05 avr. 2024 | OTHER | NGM BIOPHARMACEUTICALS INC | 255 000 | — | deriv |
| 16 janv. 2024 | TAX_WITHHOLDING | NGM BIOPHARMACEUTICALS INC | 13 032 | 1.34 USD | |
| 06 nov. 2023 | OTHER | NGM BIOPHARMACEUTICALS INC | 500 000 | — | deriv |
| 06 nov. 2023 | GRANT_AWARD | NGM BIOPHARMACEUTICALS INC | 500 000 | — | deriv |
| 06 nov. 2023 | OTHER | NGM BIOPHARMACEUTICALS INC | 450 000 | — | deriv |
| 06 nov. 2023 | GRANT_AWARD | NGM BIOPHARMACEUTICALS INC | 450 000 | — | deriv |
| 06 nov. 2023 | OTHER | NGM BIOPHARMACEUTICALS INC | 400 000 | — | deriv |
| 06 nov. 2023 | GRANT_AWARD | NGM BIOPHARMACEUTICALS INC | 400 000 | — | deriv |
| 06 nov. 2023 | OTHER | NGM BIOPHARMACEUTICALS INC | 200 000 | — | deriv |
| 06 nov. 2023 | GRANT_AWARD | NGM BIOPHARMACEUTICALS INC | 200 000 | — | deriv |